Lunai Bioworks (LNAI) Amortization of Goodwill (2024 - 2025)

Lunai Bioworks (LNAI) recorded quarterly Amortization of Goodwill of $122.8 million in Q2 2025, up 157.91% quarter-over-quarter from $47.6 million in Q3 2024.

Lunai Bioworks (LNAI) Amortization of Goodwill (2024 - 2025) Analysis & Trends

Lunai Bioworks' Amortization of Goodwill history runs 2 years deep, the most recent figure standing at $122.8 million for Q2 2025.

  • In Q2 2025, Amortization of Goodwill changed N/A year-over-year to $122.8 million; the TTM figure through Jun 2025 stood at $170.4 million (changed N/A YoY), while the FY2025 annual figure was $170.4 million, up 1364.08% from the prior year.
  • Amortization of Goodwill was $122.8 million for Q2 2025 at Lunai Bioworks, up from $47.6 million in the prior quarter.
  • In the past five years, Amortization of Goodwill ranged from a high of $122.8 million in Q2 2025 to a low of $47.6 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Lunai Bioworks 95.85 Mn 92.70 Mn 20,942.00

Historic Data

Download Data
DateValue
Jun 30, 2025 122.80 Mn
Jun 30, 2025 122.80 Mn
Sep 30, 2024 47.61 Mn
Sep 30, 2024 47.61 Mn